Data Group Wants Entire AI Market

Company sees 17% premarket surge after record demand for artificial intelligence. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Good morning Wake-up Watchlisters! While you're sipping coffee you'll see US stock futures saw a broad decline on Tuesday. The drop was triggered by Swedish landlord SBB halting dividends, and weaker-than-expected economic data from China. European stocks and US futures also traded lower, along with oil. Investors will be closely watching efforts in Washington to resolve the US debt ceiling impasse, as President Biden meets with House Speaker Kevin McCarthy for the first time in three months. Yesterday in the War Room we mentioned how the debt ceiling drama was largely political theater and likely nothing to worry about. It's crucial to stick to sound trading fundamentals and avoid distracting narratives, which is exactly what we'll be doing this week. Click here to learn more about how we use the "Perfect Timing Pattern" to make consistent winning trades in both bull and bear markets. Palantir Technologies (NYSE: PLTR) Palantir Technologies Inc., a data analysis company, is up 17.70% in premarket trading after the firm delivered a strong earnings forecast and reported unprecedented demand for its new artificial intelligence tool. The company achieved a surprise profit in Q1 and anticipates remaining profitable throughout 2023, marking its first profitable year. Palantir's CEO, Alex Karp, emphasized the firm's focus on AI, stating that it is "running hard" at AI technology and intends to take the entire market. Artificial intelligence has been the hot topic in 2023, and there's another potentially game-changing tech company our friend Andy Snyder wants you to know about. It's not 5G or crypto, and there's reason to believe it could be worth up to $13 trillion by 2030. Click here to unlock this tech stock. Paypal (Nasdaq: PYPL) Paypal is down 4.99% premarket despite reporting better-than-expected earnings and increasing its full-year profit forecast. The company's adjusted earnings for Q1 2021 rose by 44.4% from the previous year, with revenues rising by 8.6% to $7.04 billion and payments volumes increasing by 12% to $354.5 billion. Although PayPal reduced costs, including a 7% reduction of its workforce, it expects its margins to weaken over the coming months. PayPal predicted Q2 earnings of between $1.15 and $1.17 per share, slightly below Refinitiv forecasts, indicating that austerity measures would have limited impact on margins during H2 2021. Yesterday we positioned ourselves on an overnight strange in PYPL in The War Room. Click here to learn more about how overnight trading could double your money while you sleep. Nobel Prize-Winning Doctor Calls This Type of Treatment "A Magic Bullet" Dr. Paul Ehrlich, the father of modern chemotherapy, dreamed of a "magic bullet" medicine... One that would target only the disease... and leave healthy cells alone. Now this Nobel Prize-winning doctor's dream is coming true. One tiny stock just received FDA approval for its "magic bullet"-style drug... And it's already racked up $2 million-plus in sales in 6 weeks. Click here for the full story... including how you can get the ticker of this tiny stock. Shoals Technologies (Nasdaq: SHLS) Shoals Technologies was up 20.94% in premarket trading after reporting its Q1 2023 results. The significant supplier of electrical balance of system (EBOS) solutions for electric vehicle charging infrastructure, solar, and battery storage, achieved a year-over-year revenue growth of 55%. Plus, it saw a 95% revenue increase for System Solutions compared to the same period the prior year. The company's backlog and awarded orders experienced a 75% year-over-year increase, reaching a record $527.5 million, showcasing the continuing strong demand for Shoals' products. Novavax (Nasdaq: NVAX) Novavax was up 8.46% in premarket trading. The biotech firm announced it plans to cut its workforce by 25% as it pushes forward with cost-cutting efforts and faces low demand for its COVID-19 vaccines. The firm anticipates total annual revenue of between $1.4 billion and $1.6 billion, which is dependent on the timely launch of its updated COVID shot. Novavax's coronavirus vaccine is its only product, and the firm has been in business for 35 years. Novavax is counting on cost controls and successful clinical trials for its COVID/flu combination vaccine candidate to help it stay afloat. A mid-stage study found that the COVID/flu combination shot was safe and well-tolerated. Our app is officially an award winner! Last week our Trade of the Day mobile app won the Award of Excellence at the 2023 Communicator Awards. This app provides you with realtime trade ideas and chart setups, all in the palm of your hand so you can use it anywhere. Click here to download it now. Those are the biggest stock movers for today. Happy trading! The Wake-Up Watchlist Research Team America's Reckoning (Seniors Devastated) If you thought things were bad now... the worst may still be ahead. The average investor could take DECADES to recover from America's Reckoning. Don't wait to prepare... Move Your Cash Before June 2 to THIS $3 Asset (NOT Gold... Commodities... or Bonds) Monument Traders Alliance   You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day. © 2023 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.